Stories > 4DMT Presents Positive Interim Data

4DMT Presents Positive Interim Data

Advancements in Cancer Treatment and Mar...

Advancing ALS Treatment through Protein ...

Biopharmaceutical Companies Merge and Pr...

4D Molecular Therapeutics Raises $300 Mi...

Biopharma Innovator GeNeuro Discloses Pr...

Biotech Collaboration for Industry Innov...